Click for best price
Leukemia Treatment Drugs Market Size, Share 2023
Leukemia Treatment Drugs is used to cure Leukemia.
This report aims to provide a comprehensive presentation of the global market for Leukemia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukemia Treatment Drugs. This report contains market size and forecasts of Leukemia Treatment Drugs in global, including the following market information:
Global Leukemia Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Leukemia Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market.
We surveyed the Leukemia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leukemia Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Leukemia Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Gleevec
Sapacitabine
GA101
Vasaroxine
Tosedosat
Revlimid
Bosutinib
Global Leukemia Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Leukemia Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Research Institutes
Diagnostic Centers
Others
Global Leukemia Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Leukemia Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leukemia Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Leukemia Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Leukemia Treatment Drugs, market overview.
Chapter 2: Global Leukemia Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Leukemia Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Leukemia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Leukemia Treatment Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Leukemia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Leukemia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Leukemia Treatment Drugs Overall Market Size
2.1 Global Leukemia Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Leukemia Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Leukemia Treatment Drugs Players in Global Market
3.2 Top Global Leukemia Treatment Drugs Companies Ranked by Revenue
3.3 Global Leukemia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Leukemia Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Leukemia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leukemia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Leukemia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Leukemia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Leukemia Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Gleevec
4.1.3 Sapacitabine
4.1.4 GA101
4.1.5 Vasaroxine
4.1.6 Tosedosat
4.1.7 Revlimid
4.1.8 Bosutinib
4.2 By Type - Global Leukemia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Leukemia Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Leukemia Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Leukemia Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research Institutes
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Leukemia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Leukemia Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Leukemia Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Leukemia Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Leukemia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Leukemia Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Leukemia Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Leukemia Treatment Drugs Revenue, 2018-2029
6.3.2 US Leukemia Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Leukemia Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Leukemia Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Leukemia Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Leukemia Treatment Drugs Market Size, 2018-2029
6.4.3 France Leukemia Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Leukemia Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Leukemia Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Leukemia Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Leukemia Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Leukemia Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Leukemia Treatment Drugs Revenue, 2018-2029
6.5.2 China Leukemia Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Leukemia Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Leukemia Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Leukemia Treatment Drugs Market Size, 2018-2029
6.5.6 India Leukemia Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Leukemia Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Leukemia Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Leukemia Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Leukemia Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Leukemia Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Leukemia Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Leukemia Treatment Drugs Market Size, 2018-2029
7 Leukemia Treatment Drugs Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Leukemia Treatment Drugs Major Product Offerings
7.1.4 GSK Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Leukemia Treatment Drugs Major Product Offerings
7.2.4 Pfizer Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Leukemia Treatment Drugs Major Product Offerings
7.3.4 Novartis AG Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Leukemia Treatment Drugs Major Product Offerings
7.4.4 Roche Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Leukemia Treatment Drugs Major Product Offerings
7.5.4 Celgene Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 Biogen
7.6.1 Biogen Company Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Leukemia Treatment Drugs Major Product Offerings
7.6.4 Biogen Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Biogen Key News & Latest Developments
7.7 Genzyme Corporation
7.7.1 Genzyme Corporation Company Summary
7.7.2 Genzyme Corporation Business Overview
7.7.3 Genzyme Corporation Leukemia Treatment Drugs Major Product Offerings
7.7.4 Genzyme Corporation Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Genzyme Corporation Key News & Latest Developments
7.8 Eisai C.
7.8.1 Eisai C. Company Summary
7.8.2 Eisai C. Business Overview
7.8.3 Eisai C. Leukemia Treatment Drugs Major Product Offerings
7.8.4 Eisai C. Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Eisai C. Key News & Latest Developments
7.9 Bristol Myers Squibb Company (BMS)
7.9.1 Bristol Myers Squibb Company (BMS) Company Summary
7.9.2 Bristol Myers Squibb Company (BMS) Business Overview
7.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Major Product Offerings
7.9.4 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Company (BMS) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Leukemia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Leukemia Treatment Drugs Market Drivers in Global Market
Table 3. Leukemia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Leukemia Treatment Drugs in Global Market
Table 5. Top Leukemia Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Leukemia Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Leukemia Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Leukemia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Leukemia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leukemia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Leukemia Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Leukemia Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Leukemia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Leukemia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Leukemia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Leukemia Treatment Drugs Product Offerings
Table 32. GSK Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Leukemia Treatment Drugs Product Offerings
Table 36. Pfizer Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Novartis AG Company Summary
Table 39. Novartis AG Leukemia Treatment Drugs Product Offerings
Table 40. Novartis AG Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis AG Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Leukemia Treatment Drugs Product Offerings
Table 44. Roche Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Celgene Company Summary
Table 47. Celgene Leukemia Treatment Drugs Product Offerings
Table 48. Celgene Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. Biogen Company Summary
Table 51. Biogen Leukemia Treatment Drugs Product Offerings
Table 52. Biogen Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Biogen Key News & Latest Developments
Table 54. Genzyme Corporation Company Summary
Table 55. Genzyme Corporation Leukemia Treatment Drugs Product Offerings
Table 56. Genzyme Corporation Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Genzyme Corporation Key News & Latest Developments
Table 58. Eisai C. Company Summary
Table 59. Eisai C. Leukemia Treatment Drugs Product Offerings
Table 60. Eisai C. Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Eisai C. Key News & Latest Developments
Table 62. Bristol Myers Squibb Company (BMS) Company Summary
Table 63. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product Offerings
Table 64. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Company (BMS) Key News & Latest Developments
List of Figures
Figure 1. Leukemia Treatment Drugs Segment by Type in 2022
Figure 2. Leukemia Treatment Drugs Segment by Application in 2022
Figure 3. Global Leukemia Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Leukemia Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Leukemia Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Leukemia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis AG Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biogen Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genzyme Corporation Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eisai C. Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
